Search Results

Use of direct oral anticoagulants for venous thromboembolism treatment at extremes of body weight, renal and liver function: an illustrated review.

• Authors : Speed V; King's Thrombosis Centre, Department of Haematological Medicine, King's College Hospital Foundation NHS Trust, London, United Kingdom.; Bennett Institute for Applied Data Science, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, United Kingdom.

• Source: Research and practice in thrombosis and haemostasis [Res Pract Thromb Haemost] 2023 Oct 31; Vol. 7 (8), pp. 102240. Date of Electronic Publication: 2023 Oct 31 (Print Publisher: Elsevier Country of Publication: United States NLM ID: 101703775 Publication Model: eCollection Cited Medium:

Record details

Physician perceptions and use of reduced-dose direct oral anticoagulants for extended phase venous thromboembolism treatment.

• Authors : Groat D; Martin KA ...

• Source: Research and practice in thrombosis and haemostasis [Res Pract Thromb Haemost] 2022 Jun 08; Vol. 6 (4), pp. e12740. Date of Electronic Publication: 2022 Jun 08 (Print Publisher: Elsevier Country of Publication: United States NLM ID: 101703775 Publication Model: eCollection Cited Medium:

Record details

Cancer-associated venous thromboembolism: Treatment and prevention with rivaroxaban.

• Authors : Bauersachs R; Department of Vascular Medicine Klinikum Darmstadt GmbH Darmstadt Germany.; Center of Thrombosis and Hemostasis University of Mainz Mainz Germany.

• Source: Research and practice in thrombosis and haemostasis [Res Pract Thromb Haemost] 2020 Apr 04; Vol. 4 (4), pp. 532-549. Date of Electronic Publication: 2020 Apr 04 (Print Publisher: Elsevier Country of Publication: United States NLM ID: 101703775 Publication Model: eCollection Cited Medium:

Record details

Direct oral anticoagulants and warfarin for venous thromboembolism treatment: Trends from 2012 to 2017.

• Authors : Lutsey PL; Division of Epidemiology & Community Health School of Public Health University of Minnesota Minneapolis Minnesota.; Walker RF

• Source: Research and practice in thrombosis and haemostasis [Res Pract Thromb Haemost] 2019 Jun 09; Vol. 3 (4), pp. 668-673. Date of Electronic Publication: 2019 Jun 09 (Print Publisher: Elsevier Country of Publication: United States NLM ID: 101703775 Publication Model: eCollection Cited Medium:

Record details

Hospital-based costs associated with venous thromboembolism treatment regimens.

• Authors : Merli G; Jefferson Center for Vascular Diseases, Thomas Jefferson University, Philadelphia, PA, USA. ; Ferrufino C

Subjects: Hospital Costs*; Venous Thromboembolism/Venous Thromboembolism/Venous Thromboembolism/*economics; Adolescent

• Source: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2008 Jul; Vol. 6 (7), pp. 1077-86. Date of Electronic Publication: 2008 Jul 01.Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium:

Record details

Results of an international survey on adherence with anticoagulation in children, adolescents, and young adults: Communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis.

• Authors : McGrady ME; Division of Behavioral Medicine and Clinical Psychology, Center for Adherence and Self-Management, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.; Patient and Family Wellness Center, Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.

Subjects: Hemostasis* ; Thrombosis*/Thrombosis*/Thrombosis*/drug therapy ; Thrombosis*/Thrombosis*/Thrombosis*/prevention & control

• Source: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2022 Jul; Vol. 20 (7), pp. 1720-1728. Date of Electronic Publication: 2022 Apr 28.Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium:

Record details

Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis.

• Authors : Khan F; School of Epidemiology and Public Health, University of Ottawa, Ottawa, ON, Canada.; Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada.

Subjects: Pulmonary Embolism* ; Venous Thromboembolism*/Venous Thromboembolism*/Venous Thromboembolism*/diagnosis ; Venous Thromboembolism*/Venous Thromboembolism*/Venous Thromboembolism*/drug therapy

• Source: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2021 Nov; Vol. 19 (11), pp. 2801-2813. Date of Electronic Publication: 2021 Aug 22.Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium:

Record details

Diagnosis and management of severe congenital protein C deficiency (SCPCD): Communication from the SSC of the ISTH.

• Authors : Minford A; Department of Paediatrics, Bradford Royal Infirmary, West Yorkshire, UK.; Brandão LR

Subjects: Disseminated Intravascular Coagulation* ; Protein C Deficiency*/Protein C Deficiency*/Protein C Deficiency*/diagnosis ; Thrombosis*/Thrombosis*/Thrombosis*/diagnosis

• Source: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2022 Jul; Vol. 20 (7), pp. 1735-1743. Date of Electronic Publication: 2022 May 15.Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium:

Record details

Venous thromboembolism in pediatric patients with acute lymphoblastic leukemia under chemotherapy treatment. Risk factors and usefulness of thromboprophylaxis. Results of LAL-SEHOP-PETHEMA-2013.

• Authors : Ruiz-Llobet A; Servicio de Hematología Pediátrica, Hospital Sant Joan de Déu Barcelona, Institut de Recerca Pediàtrica, Hospital San Joan de Déu de Barcelona (IRP-HSJD), Universitat de Barcelona, Barcelona, Spain.; Instituto Nacional de Investigación Biomédica en Enfermedades Raras (CIBER ER), Instituto de Salud Carlos III, Madrid, España.

Subjects: Precursor Cell Lymphoblastic Leukemia-Lymphoma*/Precursor Cell Lymphoblastic Leukemia-Lymphoma*/Precursor Cell Lymphoblastic Leukemia-Lymphoma*/complications ; Precursor Cell Lymphoblastic Leukemia-Lymphoma*/Precursor Cell Lymphoblastic Leukemia-Lymphoma*/Precursor Cell Lymphoblastic Leukemia-Lymphoma*/drug therapy ; Thrombophilia*/Thrombophilia*/Thrombophilia*/complications Thrombophilia, hereditary

• Source: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2022 Jun; Vol. 20 (6), pp. 1390-1399. Date of Electronic Publication: 2022 Mar 27.Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium:

Record details

Symptomatic pulmonary embolus after catheter removal in children with catheter related thrombosis: A report from the CHAT Consortium.

• Authors : Jaffray J; Children's Hospital Los Angeles, Los Angeles, California, USA.; Department of Pediatrics, University of Southern California Keck School of Medicine, Los Angeles, California, USA.

Subjects: Catheterization, Central Venous*/Catheterization, Central Venous*/Catheterization, Central Venous*/adverse effects ; Central Venous Catheters*/Central Venous Catheters*/Central Venous Catheters*/adverse effects ; Pulmonary Embolism*/Pulmonary Embolism*/Pulmonary Embolism*/complications

• Source: Journal of thrombosis and haemostasis : JTH [J Thromb Haemost] 2022 Jan; Vol. 20 (1), pp. 133-137. Date of Electronic Publication: 2021 Oct 19.Publisher: Elsevier Country of Publication: England NLM ID: 101170508 Publication Model: Print-Electronic Cited Medium:

Record details